We aimed to evaluate the in vitro osteogenic and osteoinductive potentials of BioS-2P and its ability to promote in vivo bone repair. To investigate osteogenic potential, UMR-106 osteoblastic cells were cultured on BioS-2P and Bioglass 45S5 discs in osteogenic medium.
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Introduction
Over the past decade, tissue engineering based on combinations of cells and biomaterials has been investigated as a feasible strategy for bone regeneration. One of the frontiers for this cell-based therapy is the development of scaffolds that act as templates to guide bone growth. The ideal scaffold should have favourable biological and mechanical properties with a suitable surface to stimulate cell adhesion, proliferation and differentiation, biodegradability and adequate mechanical strength [1] [2] [3] [4] .
Since 1969, when Hench discovered the melt-derived bioactive glass, which is called Bioglass 45S5, many investigations have been performed aimed at its different biological applications [5, 6] . A major step development in this field was the demonstration that bioactive glasses can bond to living bone [7] . More recently, the term "osteostimulation" was coined to refer to the mechanisms triggered by bioactive glasses in the body to repair bone [5, 8] . Despite the outstanding biological properties of Bioglass 45S5, which is available in several forms including porous blocks, the generation of scaffolds with improved mechanical strength without affecting biocompatibility has been a key challenge in the scientific community [9] [10] [11] [12] [13] .
In this scenario, the development of new glass formulations to overcome this mechanical limitation would be very welcome. A glass-ceramic with the composition 23.75Na 2 O-23.75CaO-48.5SiO 2 -4P 2 O 5 (wt%) named Biosilicate ® was created to combine bioactivity properties with mechanical strength [14] . Under controlled heat treatment, Biosilicate ® can be produced with one (BioS-1P) or two (BioS-2P) crystalline phases that have an associated increase in the elastic modulus and fracture strength [15, 16] . BioS-1P
increases in vitro extracellular matrix mineralization in an osteogenic cell culture system and preserves the dental alveolar ridge height, which allowed for titanium implant osseointegration in a pre-clinical animal model [17, 18] . The BioS-2P can be produced as 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t 4 scaffolds and exhibits a similar response to BioS-1P and Bioglass 45S5 in terms of contact with bone [19] .
Several biological and mechanical features make Biosilicate ® an appealing candidate to fabricate scaffolds for bone regeneration. However, the effects of this secondary crystalline phase are underexplored and needs to be investigated. Thus, the aim of this study was to evaluate both the in vitro osteogenic and osteoinductive potentials of BioS-2P and their effects on in vivo bone repair. Furthermore, we evaluated if BioS-2P
scaffold combined with mesenchymal stem cells (MSCs) could improve bone formation.
Materials and methods

Sample preparation and characterization
High-purity silica (Zetasil 3, Santa Rosa Mineração, Pequeri, MG, Brazil) and reagent grade calcium carbonate (JT Baker, Center Valley, PA, USA), sodium carbonate (JT Baker), and monosodium phosphate (JT Baker) were used to produce Biosilicate ® parent glass and Bioglass 45S5. The chemicals were blended overnight and then they were melted in a platinum crucible at 1450°C for 4 h, splat-cooled and re-melted three times (every 1 h).
Finally, the melts were cast into a cylindrical stainless steel mould 50 mm in height by 12 mm in diameter. Biosilicate ® parent glass was fully crystallized using a double stage heattreatment first for crystal nucleation (565°C/100 h) and then for crystal growth (665°C/1 h).
To obtain Biosilicate ® containing two crystalline phases (BioS-2P), an additional heattreatment was performed at 800°C/1 h. The cylinders of BioS-2P glass-ceramic and Bioglass 45S5 were cut into 3-mm-thick discs. The discs were ground using silicon carbide paper to a grit of 400 (~35 µm) and cleaned with isopropyl alcohol (99.8%) in an ultrasonic cleaner for 1 min. The scaffolds were obtained from BioS-2P as previously described [20] . Briefly, a suspension containing BioS-2P powder mixed with carbon black 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t was dried, pressed and sintered (975°C/5 h) to produce porous scaffolds with 5 mm in diameter and 2 mm in height. Prior to cell culture experiments and surgical procedures, all samples were submitted to sterilization using dry heat at 180°C for 2 h.
X-ray diffraction (XRD) and optical microscopy
The ground solid discs (grit 400) of BioS-2P were analysed via X-ray diffraction (Ultima IV, Rigaku, Japan). A step scan mode (0.01°/s), i.e., a count time of 4 s, from 10 to 90° was used. The crystalline phases present in BioS-2P were identified using Crystallographica Search-Match software (version 2.1.1.1, Oxford Cryo Systems, Murray Hill, NJ, USA). After surface-polishing, BioS-2P discs were analysed using an optical microscope (Eclipse LV100NPOL, Nikon, Japan) attached to a digital camera (DSFi2, Nikon). On the surface, images were captured using reflected light. From 1.5 to 8.5 µm below the surface, images were automatically captured every 0.1 µm using polarized light.
The images were merged, and a focused 3D image was created using the imaging software NIS Elements, version 4.20 (Nikon).
Microtomography and morphometric analysis
BioS-2P scaffolds were evaluated by micro-CT using the SkyScan 1172 system (Bruker, Sky-Scan, Belgium). The images were generated at 60 kV and 200 mA using isotropic voxel 5.88 µm and the reconstructions were made using NRecon software (1.6.10.4 version, Bruker) with smoothing set at 1, ring artefact correction set at 5 and beam hardening correction set at 20%. Three samples were scanned to evaluate the percentage of total porosity and pore size distribution.
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Osteogenic potential of BioS-2P
Culture of UMR-106 osteoblastic cell line
The rat osteoblastic cell line UMR-106 (American Type Culture Collection, Manassas, VA, USA) was cultivated in growth medium (non-osteogenic conditions) constituted by alphaminimum essential medium (α-MEM, Gibco-Life Technologies, Grand Island, NY, USA)
supplemented with 10% foetal bovine serum (Gibco-Life Technologies), 50 µg/ml penicillin/streptomycin (Gibco-Life Technologies) and 0.3 µg/ml fungizone (Gibco-Life Technologies). After subconfluence, cells from first passage were cultured in 24-well culture plates on BioS-2P and Bioglass 45S5 discs at a cell density of 2x10 4 cells/well in osteogenic medium. This medium was composed by growth medium supplemented with 5 µg/ml ascorbic acid (Gibco-Life Technologies) and 7 mM β-glycerophosphate (SigmaAldrich, Saint Louis, MO, USA). The cultures were kept at 37°C in a humidified atmosphere of 5% CO 2 and 95% air, the medium was replaced every 48 h, and all assays were done on day 5.
Cell culture growth
Cell culture growth was assessed with a 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT, Sigma-Aldrich) assay. The MTT absorbance was measured as optical density at 570 nm using a µQuant plate reader (Biotek, Winooski, VT, USA). The data were collected in quintuplicate (n=5).
In situ alkaline phosphatase (ALP) activity
In situ ALP activity was analysed with a Fast Red assay. The cultures were washed in
Hank's balanced salt solution (Sigma-Aldrich) and incubated for 30 min at 37°C with 0.5 ml of 120 mM Tris buffer (Sigma-Aldrich), pH 8.4, containing 0.9 mM naphthol AS-MX A c c e p t e d M a n u s c r i p t phosphate (Sigma-Aldrich) and 1.8 mM Fast red TR (Sigma-Aldrich). The cells were washed and dried at room temperature. The images were obtained using a high-resolution camera (Canon EOS Digital Rebel, Canon, Tokyo, Japan), processed and then quantified using Image J software [21] . The data were collected in quintuplicate (n=5).
Gene expression of osteoblast markers
Gene expression of ALP, bone sialoprotein (BSP), runt-related transcription factor 2 (RUNX2) and osteopontin (OPN) was evaluated with real-time PCR. Total RNA (1 µg) was used to synthesize complementary DNA (cDNA) in a reverse transcription reaction (M-MLV reverse transcriptase, Promega Corporation, Madison, WI, USA). Real-time PCR was done using a CFX96 Real-Time PCR Detection System (Bio-Rad Laboratories, Philadelphia, PA, USA). Relative gene expression, which was collected in quadruplicate (n=4), was normalized to the constitutive gene GAPDH, and the real change was relative to the gene expression of cells cultivated on Bioglass 45S5.
Detection of bone-related proteins
The proteins BSP and OPN were detected by immunofluorescence labelling. The cells were fixed, permeabilized and blocked with 5% non-fat powdered milk (Bio-Rad A c c e p t e d M a n u s c r i p t phenylindole, dihydrochloride (DAPI, Molecular Probes). The discs were observed using a fluorescence microscope Axio Imager M2 (Carl Zeiss), and the captured images were treated using Adobe Photoshop software.
The proteins ALP and RUNX2 were detected using Western blotting. A sample of total protein (70 µg) was submitted to electrophoresis in a denaturing 8.5% polyacrylamide gel. Then, proteins were transferred to a Hybond C-Extra membrane (GE Healthcare Life Science, Piscataway, NJ, USA) using a semidry transfer system (Bio-Rad Laboratories). 
Extracellular matrix mineralization
The Von Kossa staining was used to detect mineralized matrix. The cultures were incubated with silver nitrate (5 mg/ml) (Sigma-Aldrich), followed by hydroquinone (5 A c c e p t e d M a n u s c r i p t mg/ml) (Sigma-Aldrich) and sodium thiosulphate (50 mg/ml) (Sigma-Aldrich). After washing and drying at room temperature, the images were obtained using a camera (Canon EOS Digital Rebel), processed and quantified using Image J software [21] . The data were collected in quintuplicate (n=5).
Osteoinductive potential of BioS-2P
Culture of mesenchymal stem cells (MSCs)
The and 95% air. The medium was changed every 48 h, and all assays were done on day 10.
ALP activity
A commercial kit (Labtest Diagnostica SA, Lagoa Santa, MG, Brazil) was used to measure ALP activity by the release of thymolphthalein from thymolphthalein monophosphate.
Absorbance was read at 590 nm using a µQuant plate reader (BioTek), and ALP activity was determined from a thymolphthalein standard curve. The data were collected in quintuplicate (n=5) and are presented as ALP activity normalized to the total protein content, which was quantified in the same cell lysates using the Lowry method [22] . A c c e p t e d M a n u s c r i p t
Gene expression of ALP, RUNX2, OPN and osteocalcin (OC) was evaluated in quadruplicate (n=4) with real-time PCR, as described above (2.2.4). The cells cultured on polystyrene were used to calculate the real changes of gene expression.
Effects of BioS-2P scaffolds on bone repair
Surgical procedures for BioS-2P scaffold implantation
Fifteen male Wistar rats weighing 200-300 g were used for the following research protocols, which were approved by the Committee of Ethics in Research from the University of São Paulo. The animals were anesthetized with ketamine (7 mg/100 g body weight; Agener União, SP, Brazil) and xylazine (0.6 mg/100 g body weight; Calier, MG, Brazil). Calvarial bone defects that were 5 mm in diameter were unilaterally created with a trephine and implanted with BioS-2P scaffolds followed by a skin suture with nylon 4.0 (Ethicon Ltd, NJ, EUA). Then, single doses of antibiotics and analgesics were administered. Four, 8 and 12 weeks post-implantation, the animals (n=5 per period) were euthanized, and the samples were harvested and prepared for morphometric and histological analyses.
Morphometric and histological analyses
After harvesting, the samples were maintained in 10% formalin buffered with 0.1 M sodium cacodylate, pH 7.0. Morphometric analysis was performed with micro-CT using the SkyScan 1172 system (Bruker). The images and reconstructions were obtained as 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t trabecular separation (Tb.Sp) of the newly formed bone were quantified using the 3D Ctan software 1.13.1.1.0 version (Bruker).
Histological analysis was carried out following a previously described protocol [23] . After micro-CT analysis, samples were kept in a solution of 70% ethanol for 72 h, followed by embedding in resin (LR White Hard Grade, London, UK) and sectioned using the Exakt Cutting System (Exakt, Norderstedt, Germany). The sections were polished, mounted on acrylic slides using the Exakt Grinding System (Exakt) and stained with Stevenel's blue and Alizarin red S. The tissues formed in the bone defects were histologically described using micrographs obtained with a Leica DMLB light microscope (Leica, Bensheim, Germany).
Effects of the association of BioS-2P with MSCs on bone repair
Cell incorporation in BioS-2P scaffolds
First-passage MSCs were obtained as described above (2.3.1), seeded by pipetting (2x10 5 cells/100 µl) into BioS-2P scaffolds, which were placed into 48-well and cultured for 18 h to allow cell adhesion. Cell incorporation was detected under epifluorescence using an ApoTome system and an Axiocam MRm digital camera (Zeiss). The efficiency of cell incorporation was evaluated by counting the non-incorporated cells that were enzymatically released from the 48-wells after BioS-2P scaffold removal. During the culture period, scaffolds were incubated at 37°C in a humidified atmosphere of 5% CO 2 and 95% air for 24 h. BioS-2P scaffolds without cells were used as controls.
Cell tracking
MSCs were transduced using a lentiviral vector with luciferase 3-5 days after passage at a multiplicity of infection (MOI) of 8. After 2 days, the medium was changed, and the cells 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t were selected using puromycin during 6 days. These cells were seeded into BioS-2P scaffolds and surgically implanted into bone defects by following the same protocols described above (2.5.1 and 2.4.1, respectively). For cell tracking, luciferase-positive cells were detected from 6 h to 28 days after implantation using the IVIS imaging system (Xenogem Corporation, CA, USA) after 100 µl of a luciferin (mg/ml) local injection.
Signal intensity was quantified as the photon flux (photons/s) within the region of interest by using IVIS Image 3.0 software (Caliper Life Sciences).
Surgical procedures for BioS-2P scaffolds with MSCs implantation
Five male Wistar rats weighing 200-300 g were used as described above (2.4.1). BioS-2P
scaffolds seeded with unlabelled MSCs were implanted in rat calvarial defects, and eight weeks post-implantation, the animals were euthanized, and the samples were collected and processed for histomorphometric and histological analyses. These data were compared to data from rats implanted with BioS-2P scaffolds without cells for eight weeks.
Statistical analysis
Quantitative data were collected in quintuplicate (n=5) for all parameters except gene expression, which were collected in quadruplicate (n=4). The comparisons between two groups (BioS-2P vs Bioglass 45S5 and BioS-2P scaffold with MSCs vs BioS-2P without MSCs) were done using Mann-Whitney test, whereas Kruskal-Wallis test followed by the Student-Newman-Keuls test were used to compare three groups (BioS-2P, Bioglass 45S5 and polystyrene; 4, 8 and 12 weeks). The significance level was set at 5%. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t
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Results
Characterization of BioS-2P
The nominal compositions of Na 2 O, CaO, SiO 2 and P 2 O 5 (mol %) of BioS-2P and Bioglass 45S5 are detailed in Table 1 . The XRD spectra showed that the main crystalline phase in BioS-2P was a sodium calcium silicate (Na 2 CaSi 2 O 6 -ICSD 060502) followed by a secondary crystalline phase (NaCaPO 4 -ICSD 035629) that presented three main diffraction peaks at 23.3°, 32.7° and 47.5°, (Fig. 1A) . The lower peak intensity of the secondary crystalline phase indicated that there was a lower crystallized volume fraction.
Optical micrographs showed grains of Na 2 CaSi 2 O 6 at the surface of the BioS-2P (Fig. 1B) but no crystals of the secondary crystalline phase. However, at a submicron scale (approximately 0.2 -0.4 µm) and below the surface, it was possible to observe the secondary crystalline phase due to its distinct optical behaviour. The bright spots that consisted of NaCaPO 4 were uniformly distributed in a matrix composed of Na 2 CaSi 2 O 6 crystals (Fig. 1C) .
The micro-CT 3D and 2D images of the BioS-2P scaffolds showed a porous structure resembling a cancellous bone (Fig. 1 D-G) . The BioS-2P scaffold presented 76±5% of porosity and pores with sizes ranging between 10 and 800 µm, whereas the majority of open pores were within 100 and 600 µm (Fig. 1H). 
Osteogenic potential of BioS-2P
To determine osteogenic potential, UMR-106 osteoblastic cells were cultured on BioS-2P and Bioglass 45S5 discs under osteogenic conditions for 5 days. No difference in culture growth was detected between BioS-2P and Bioglass 45S5 (p=0.886; Fig. 2A 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t while no statistically significant difference in the expression of ALP was observed between the bioactive surfaces (p=0.200) (Fig. 2C ). BSP and OPN proteins were detected in cells cultivated on both surfaces with marked expression on BioS-2P compared to Bioglass 45S5 (Fig. 2D ). Higher protein expression of ALP and RUNX2 was also observed in cells cultured on BioS-2P compared to Bioglass 45S5 (Fig. 2E) . Extracellular matrix mineralization increased in cells cultured on BioS-2P compared to Bioglass 45S5 (p=0.029; Fig. 2F ).
Osteoinductive potential of BioS-2P
To determine osteoinductive potential, MSCs were cultured on BioS-2P, Bioglass 45S5
and polystyrene under non-osteogenic conditions for 10 days. The ALP activity was greater in cells cultured on Bioglass 45S5 compared to BioS-2P and lower in cells cultured on polystyrene (p=0.001; Fig. 3A) . Furthermore, the gene expression of all evaluated osteoblast markers was higher on bioactive glasses than on polystyrene (p=0.001 for all genes; Fig. 3B-E) . By comparing only the bioactive materials, the gene expression of ALP was higher in cells cultured on BioS-2P, whereas RUNX2, OPN and OC expression was higher on Bioglass 45S5 (Fig. 3B ).
Effects of the BioS-2P scaffold on bone repair
Three-dimensional micro-CT images demonstrated that BioS-2P promoted bone repair ( Fig. 4A-C) . Morphometric analysis showed there were no differences in all evaluated 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t the centre of the bone defect (Fig 5 A-C) , the transversal slices revealed that BioS-2P scaffolds remarkably improved bone formation that was integrated with the parent lamellar bone at the defect margins (Fig 5 D-F) . Higher magnifications showed cancellous bone in direct contact with BioS-2P (Fig 5 G-I) .
Effects of the association of BioS-2P scaffold and MSCs on bone repair
MSCs could be seen within the pores of BioS-2P scaffolds (Fig. 6A) , and around of 80% of the seeded cells were incorporated into the scaffolds (Fig. 6B) . Cell tracking showed that MSCs were detected in the bone defects for 4 weeks with a peak at 1 week (Fig. 6C ).
Reconstructed images generated by micro-CT showed that the BioS-2P scaffold alone or combined with MSCs promoted similar bone repair (Fig. 7 A-B) . Morphometric analysis confirmed this observation because no differences in all evaluated parameters were found despite the presence of cells (BS p=0.589; BV p=0.180; BS/BV p=0.589; BV/TV=0.180; Tb.Th p=0.818; Tb.Sp p=0.937) (Fig. 7 C-H) . The histological observations confirmed the micro-CT findings. The axial images showed bone formation in the centre and at the border of the bone defects ( Fig. 8 A-B) . Higher magnifications showed a direct contact between bone tissue and BioS-2P (Fig. 8 C-D) .
Discussion
Here, we reported that BioS-2P had a secondary crystalline phase and presented an architecture that resembled a cancellous bone. BioS-2P displayed in vitro osteogenic and osteoinductive properties and enhanced the repair of bone tissue in a rat calvarial defect model. Under standard osteogenic conditions, BioS-2P stimulated the osteoblast activity of the UMR-106 cell line and generated a microenvironment that promoted the induction of osteoblast phenotype and genotype expression in MSCs grown without osteogenic factors. A c c e p t e d M a n u s c r i p t
We also noticed that the BioS-2P scaffold is able to stimulate bone formation in such magnitude that its association with MSCs was not able to increase.
We confirmed that the secondary crystalline phase present in BioS-2P was a sodium-calcium phosphate (NaCaPO 4 ) that was difficult to identify due to its low crystallized volume fraction. This phase was also detected in Bioglass 45S5 as well as in other glass-ceramics after heat treatment at temperatures of approximately 1000°C, and the phase was identified as α-or β-rhenanite [24-27]. The secondary crystalline phase was highly reactive in simulated body fluid and acted as a heterogeneous nuclei for hydroxycarbonate apatite growth at glass-ceramic surfaces, including Biosilicate ® [16, [27] [28] , and it improved the mechanical strength, elastic modulus and fracture toughness without affecting the bioactivity index [14] . These features favoured scaffold fabrication with ideal porosity and a porous network, which were able to maintain their integrity The ability of scaffolds to be populated by osteoblasts is very important for therapies that aim to regenerate bone tissue. Our results showed a similar pattern of culture growth on BioS-2P and on Bioglass 45S5 discs. In a previous study, it was observed that osteoblasts derived from rat calvarial cells grown on BioS-1P and Bioglass 45S5 exhibited the same proliferation rate [17] . These findings strongly suggested that the presence of one or two crystalline phases did not impact the capacity of Biosilicate ® to support cell attachment and proliferation. In both situations, the dynamics of growth followed the growth for Bioglass 45S5.
Bioactive glasses can induce osteoblast differentiation and extracellular matrix mineralization [17, 32] . To track the role of BioS-2P in driving osteoblast functions in UMR-106 cells, we analysed the activity of ALP, which is a key enzyme in the process of mineralization [33] . Higher ALP activity was detected in BioS-2P, which could lead to a investigate the hypothesis that BioS-2P by itself could affect osteoblast differentiation. In addition to using polystyrene as a control, BioS-2P was also compared to Bioglass 45S5 to determine the osteoinductive potential of both materials. We observed that BioS-2P upregulated ALP activity and the gene expression of ALP, RUNX2, OPN and OC compared to polystyrene. Although the ALP activity and the expression of the majority of genes were higher for Bioglass 45S5 compared to BioS-2P, our results clearly showed the ability of BioS-2P to induce osteoblast differentiation in MSCs. Similar to these results, another study showed that Bioglass 45S5-conditioned medium favours osteoblast differentiation in the absence of osteogenic factors [40] .
Beyond the in vitro osteogenic and osteoinductive properties, the BioS-2P scaffold promoted in vivo bone formation. It was noteworthy that many areas of bone formation A c c e p t e d M a n u s c r i p t were seen at the centre of the defects and were not related to the parent bone, which suggested BioS-2P had a stimulatory effect. Additionally, the observation of direct contact between the BioS-2P surface and bone corroborated the beneficial effects of BioS-2P.
However, the effects of BioS-2P were somewhat limited, so no fully defective regeneration was observed, and there was no increase in bone formation during the implantation time.
Similar to this outcome, meaningful bone formation was observed for BioS-1P and BioS-2P implanted in rabbit femurs and rat tibias [19, 41] .
The effects of combining scaffolds and cells on bone formation have produced contradictory outcomes. Some studies reported synergistic effects [42] [43] [44] [45] [46] , while others failed to show improved bone formation when MSCs were combined with scaffolds [31, 47, 48] . Our results aligned with the latter studies because the combination of BioS-2P with
MSCs did not increase bone repair. This result could have arisen, at least in part, due to the absence of cells, the scaffold architecture or the number of seeded cells [47] . However, it is most likely that none of these factors played a role in this study. The BioS-2P scaffold presented physical characteristics close to the ideal in terms of porosity and pore size. The incorporation method allowed for seeding approximately 80% of the cells to the scaffolds, and the cell tracking showed that the cells were present in the defects for a long time. It seems that the stimulatory effect of the BioS-2P on bone healing could not be enhanced by the addition of MSCs due to modifications in the microenvironment caused by the dissolution products of glassy materials that may have masked the cellular effects [39, 49] .
On the other hand, it is not possible to rule out that by using a higher cell density, a synergistic effect could be detected.
Conclusion
We showed that BioS-2P displayed a sodium-calcium silicate and a sodium- 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t Tables   Table 1 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t
Page 18 of 37 AUTHOR SUBMITTED MANUSCRIPT -BMM-101787.R1
Figure Captions
